Desipramine and citalopram attenuate pretest swim-induced increases in prodynorphin immunoreactivity in the dorsal bed nucleus of the stria terminalis and the lateral division of the central nucleus of the amygdala in the forced swimming test

Neuropeptides

Volumn 48, Issue 5, 2014, Pages 273-280

  Chung, Sung ^a   Kim, Hee Jeong ^a   Kim, Hyun Ju ^a   Choi, Sun Hye ^a   Cho, Jin Hee ^a   Cho, Yun Ha ^a   Kim, Dong Hoon ^a   Shin, Kyung Ho ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Amygdala; Antidepressive agents; Bed nucleus of stria terminalis; FST; Prodynorphin

Indexed keywords

CITALOPRAM; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DESIPRAMINE; MESSENGER RNA; PRODYNORPHIN; ANTIDEPRESSANT AGENT; ENKEPHALIN; PREPROENKEPHALIN; PROTEIN PRECURSOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; FORCED SWIM TEST; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; LATERAL AMYGDALA; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STRIA TERMINALIS; ANIMAL; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; MENTAL STRESS; METABOLISM; PHOSPHORYLATION; SEPTUM NUCLEUS; SWIMMING;

ANIMALS; ANTIDEPRESSIVE AGENTS; CENTRAL AMYGDALOID NUCLEUS; CITALOPRAM; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DESIPRAMINE; ENKEPHALINS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED ICR; PHOSPHORYLATION; PROTEIN PRECURSORS; RNA, MESSENGER; SEPTAL NUCLEI; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84908203981     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2014.07.001     Document Type: Article

References (53)

1. Arvidsson U., Riedl M., Chakrabarti S., Vulchanova L., Lee J.H., Nakano A.H., Lin X., Loh H.H., Law P.Y., Wessendorf M.W. The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:5062-5066.
2. Bienkowski M.S., Rinaman L. Common and distinct neural inputs to the medial central nucleus of the amygdala and anterior ventrolateral bed nucleus of stria terminalis in rats. Brain Struct. Funct. 2013, 218:187-208.
3. Bilang-Bleuel A., Rech J., De Carli S., Holsboer F., Reul J.M.H.M. Forced swimming evokes a biphasic response in CREB phosphorylation in extrahypothalamic limbic and neocortical brain structures in the rat. Eur. J. Neurosci. 2002, 15:1048-1060.
4. Burke M.C., Letts P.A., Krajewski S.J., Rance N.E. Coexpression of dynorphin and neurokinin B immunoreactivity in the rat hypothalamus: morphologic evidence of interrelated function within the arcuate nucleus. J. Comp. Neurol. 2006, 498:712-726.
5. Carlezon W.A., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., Nestler E.J. Regulation of cocaine reward by CREB. Science 1998, 282:2272-2275.
6. Carr K.D., Kutchukhidze N., Park T.H. Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala. Brain Res. 1999, 822:34-42.
7. Chartoff E.H., Papadopoulou M., MacDonald M.L., Parsegian A., Potter D., Konradi C., Carlezon W.A. Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue. Mol. Pharmacol. 2009, 75:704-712.
8. Choi S.H., Chung S., Cho J.H., Cho Y.H., Kim J.W., Kim J.M., Kim H.J., Kim H.J., Shin K.H. Changes in c-Fos expression in the forced swimming test: common and distinct modulation in rat brain by desipramine and citalopram. Korean J. Physiol. Pharmacol. 2013, 17:321-329.
9. Clark M.S., McDevitt R.A., Neumaier J.F. Quantitative mapping of tryptophan hydroxylase-2, 5-HT1A, 5-HT1B, and serotonin transporter expression across the anteroposterior axis of the rat dorsal and median raphe nuclei. J. Comp. Neurol. 2006, 498:611-623.
10. Cole R.L., Konradi C., Douglass J., Hyman S.E. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 1995, 14:813-823.
11. Cryan J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 2005, 29:547-569.
12. Davis M., Walker D.L., Miles L., Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 2010, 35:105-135.
13. Delgado P.L., Moreno F.A. Role of norepinephrine in depression. J. Clin. Psychiatry 2000, 61(Suppl. 1):5-12.
14. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
15. Dong H.-W., Swanson L.W. Organization of axonal projections from the anterolateral area of the bed nuclei of the stria terminalis. J. Comp. Neurol. 2004, 468:277-298.
16. Dong H.W., Petrovich G.D., Watts A.G., Swanson L.W. Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J. Comp. Neurol. 2001, 436:430-455.
17. Dziedzicka-Wasylewska M., Faron-Górecka A., Kuśmider M., Drozdowska E., Rogóz Z., Siwanowicz J., Caron M.G., Bönisch H. Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Neuropsychopharmacology 2006, 31:2424-2432.
18. Fallon J.H., Leslie F.M. Distribution of dynorphin and enkephalin peptides in the rat brain. J. Comp. Neurol. 1986, 249:293-336.
19. Fallon J.H., Leslie F.M., Cone R.I. Dynorphin-containing pathways in the substantia nigra and ventral tegmentum: a double labeling study using combined immunofluorescence and retrograde tracing. Neuropeptides 1985, 5:457-460.
20. Gilpin N.W., Roberto M. Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence. Neurosci. Biobehav. Rev. 2012, 36:873-888.
21. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., Cassano T., Morgese M.G., Debonnel G., Duranti A., Tontini A., Tarzia G., Mor M., Trezza V., Goldberg S.R., Cuomo V., Piomelli D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:18620-18625.
22. Hooker J.M., Patel V., Kothari S., Schiffer W.K. Metabolic changes in the rodent brain after acute administration of salvinorin A. Mol. Imag. Biol. 2009, 11:137-143.
23. Hurd Y.L. Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain. Neuroscience 1996, 72:767-783.
24. Kakidani H., Furutani Y., Takahashi H., Noda M., Morimoto Y., Hirose T., Asai M., Inayama S., Nakanishi S., Numa S. Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor. Nature 1982, 298:245-249.
25. Kastenberger I., Lutsch C., Herzog H., Schwarzer C. Influence of sex and genetic background on anxiety-related and stress-induced behaviour of prodynorphin-deficient mice. PLoS One 2012, 7:e34251.
26. Knoll A.T., Carlezon W.A. Dynorphin, stress, and depression. Brain Res. 2010, 1314:56-73.
27. Kulikov A.V., Tikhonova M.A., Osipova D.V., Kulikov V.A., Popova N.K. Association between tryptophan hydroxylase-2 genotype and the antidepressant effect of citalopram and paroxetine on immobility time in the forced swim test in mice. Pharmacol. Biochem. Behav. 2011, 99:683-687.
28. Land B.B., Bruchas M.R., Lemos J.C., Xu M., Melief E.J., Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J. Neurosci. 2008, 28:407-414.
29. Li C., Pleil K.E., Stamatakis A.M., Busan S., Vong L., Lowell B.B., Stuber G.D., Kash T.L. Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling. Biol. Psychiatry 2012, 71:725-732.
30. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. 1997, 2:22.
31. Mague S.D., Pliakas A.M., Todtenkopf M.S., Tomasiewicz H.C., Zhang Y., Stevens W.C., Jones R.M., Portoghese P.S., Carlezon W.A. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J. Pharmacol. Exp. Ther. 2003, 305:323-330.
32. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 1995, 18:22-29.
33. Marchant N.J., Densmore V.S., Osborne P.B. Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division. J. Comp. Neurol. 2007, 504:702-715.
34. McLaughlin J.P., Marton-Popovici M., Chavkin C. Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J. Neurosci. 2003, 23:5674-5683.
35. Messersmith D.J., Kim D.J., Iadarola M.J. Transcription factor regulation of prodynorphin gene expression following rat hindpaw inflammation. Mol. Brain Res. 1998, 53:259-269.
36. Muschamp J.W., Carlezon W.A. Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation. Cold Spring Harb. Perspec. Med. 2013, 3:a012005.
37. National Research Council Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research 2003, The National Academies Press, Washington.
38. Ni Y.G., Gold S.J., Iredale P.A., Terwilliger R.Z., Duman R.S., Nestler E.J. Region-specific regulation of RGS4 (Regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J. Neurosci. 1999, 3674-3680.
39. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates: Compact 2003, Academic Press, Second Edition. Second ed.
40. Pliakas A.M., Carlson R.R., Neve R.L., Konradi C., Nestler E.J., Carlezon W.A. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci. 2001, 21:7397-7403.
41. Poulin J.-F., Arbour D., Laforest S., Drolet G. Neuroanatomical characterization of endogenous opioids in the bed nucleus of the stria terminalis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1356-1365.
42. Przewłocki R., Lasón W., Konecka A.M., Gramsch C., Herz A., Reid L.D. The opioid peptide dynorphin, circadian rhythms, and starvation. Science 1983, 219:71-73.
43. Reed B., Fang N., Mayer-Blackwell B., Chen S., Yuferov V., Zhou Y., Kreek M.J. Chromatin alterations in response to forced swimming underlie increased prodynorphin transcription. Neuroscience 2012, 220:109-118.
44. Reyes B.A.S., Drolet G., Van Bockstaele E.J. Dynorphin and stress-related peptides in rat locus coeruleus: contribution of amygdalar efferents. J. Comp. Neurol. 2008, 508:663-675.
45. Sakai N., Thome J., Newton S.S., Chen J., Kelz M.B., Steffen C., Nestler E.J., Duman R.S. Inducible and brain region-specific CREB transgenic mice. Mol. Pharmacol. 2002, 61:1453-1464.
46. Swank M.W. Phosphorylation of MAP kinase and CREB in mouse cortex and amygdala during taste aversion learning. NeuroReport 2000, 11:1625-1630.
47. Tanis K.Q., Duman R.S., Newton S.S. CREB binding and activity in brain: regional specificity and induction by electroconvulsive seizure. Biol. Psychiatry 2008, 63:710-720.
48. Tejeda H.A., Shippenberg T.S., Henriksson R. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders. Cell. Mol. Life Sci. 2012, 69:857-896.
49. Walker D.L., Davis M. Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Struct. Funct. 2008, 213:29-42.
50. Walker D.L., Toufexis D.J., Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur. J. Pharmacol. 2003, 463:199-216.
51. Weber M., Lauterburg T., Tobler I., Burgunder J.M. Circadian patterns of neurotransmitter related gene expression in motor regions of the rat brain. Neurosci. Lett. 2004, 358:17-20.
52. Wittmann W., Schunk E., Rosskothen I., Gaburro S., Singewald N., Herzog H., Schwarzer C. Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone. Neuropsychopharmacology 2009, 34:775-785.
53. Wong E.H., Sonders M.S., Amara S.G., Tinholt P.M., Piercey M.F., Hoffmann W.P., Hyslop D.K., Franklin S., Porsolt R.D., Bonsignori A., Carfagna N., McArthur R.A. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol. Psychiatry 2000, 47:818-829.